PRV-015: A monoclonal antibody treatment in late-stage trials for celiac disease Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials ..read more

New insights into the way gluten causes damage in celiac disease revealed in Beyond Celiac funded research Results of research funded by Beyond Celiac point to a more precise way that gluten sets off damage to the intestine in those who have celiac disease and could help in the development of innovative approaches to finding a treatment ..read more

Supplements, mineral deficiencies and celiac disease What’s the point of follow-up testing and monitoring ..read more